These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7944868)

  • 1. [Management of patients with risk of sudden death. The amiodarone example].
    Djian J
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
    N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
    Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
    Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of amiodarone.
    Nolan PE; Nappi J; Pollak PT
    Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
    Funck-Brentano C
    Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amiodarone and secondary prevention. The EMIAT study].
    Munoz A
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?].
    Galinier M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1999 Jun; 92(6):727-32. PubMed ID: 10410811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
    Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmic therapy and cardiac failure].
    Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
    Kuck KH
    Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.